Nivolumab

Nivolumab Reactions 1704, p282 - 2 Jun 2018 Radiation recall dermatitis: case report A 70-year-old man developed radiation recall dermatitis secondary to nivolumab therapy [dosage and route not stated]. The man was diagnosed with metastatic non-small cell lung and was started on nivolumab (PD-1 inhibitor). He also had liver metastases, which was treated with course of radiotherapy to both the liver and upper lobe of right lung 6 months before. However, within 2 weeks of the start of the treatment with nivolumab, he developed two distinct rashes, both erythematous and scaly in appearance across both his abdomen and upper chest. The rashes were comparable to radiotherapy sites. The diagnosis was persistent with radiation recall dermatitis [outcome not stated]. Author comment: "This is the first recorded incidence of a radiation recall dermatitis associated with a PD-1 inhibitor." Mazzoni D, et al. Radiation recall dermatitis secondary to PD-1 Inhibitor. A new adverse reaction. Australasian Journal of Dermatology 59 (Suppl. 1): 86, May 2018. Available from: URL: http://doi.org/10.1111/ajd.17_12815 [abstract] - Australia 803323585 » Editorial comment: 0114-9954/18/1704-0001/$14.95 Adis © 2018 Springer International Publishing AG. All rights reserved Reactions 2 Jun 2018 No. 1704 http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Reactions Weekly Springer Journals

Nivolumab

Reactions Weekly , Volume 1704 (1) – Jun 2, 2018
Free
1 page
Loading next page...
1 Page
 
/lp/springer_journal/nivolumab-SzFBFESK0E
Publisher
Springer International Publishing
Copyright
Copyright © 2018 by Springer International Publishing AG, part of Springer Nature
Subject
Medicine & Public Health; Drug Safety and Pharmacovigilance; Pharmacology/Toxicology
ISSN
0114-9954
eISSN
1179-2051
D.O.I.
10.1007/s40278-018-46925-4
Publisher site
See Article on Publisher Site

Abstract

Reactions 1704, p282 - 2 Jun 2018 Radiation recall dermatitis: case report A 70-year-old man developed radiation recall dermatitis secondary to nivolumab therapy [dosage and route not stated]. The man was diagnosed with metastatic non-small cell lung and was started on nivolumab (PD-1 inhibitor). He also had liver metastases, which was treated with course of radiotherapy to both the liver and upper lobe of right lung 6 months before. However, within 2 weeks of the start of the treatment with nivolumab, he developed two distinct rashes, both erythematous and scaly in appearance across both his abdomen and upper chest. The rashes were comparable to radiotherapy sites. The diagnosis was persistent with radiation recall dermatitis [outcome not stated]. Author comment: "This is the first recorded incidence of a radiation recall dermatitis associated with a PD-1 inhibitor." Mazzoni D, et al. Radiation recall dermatitis secondary to PD-1 Inhibitor. A new adverse reaction. Australasian Journal of Dermatology 59 (Suppl. 1): 86, May 2018. Available from: URL: http://doi.org/10.1111/ajd.17_12815 [abstract] - Australia 803323585 » Editorial comment: 0114-9954/18/1704-0001/$14.95 Adis © 2018 Springer International Publishing AG. All rights reserved Reactions 2 Jun 2018 No. 1704

Journal

Reactions WeeklySpringer Journals

Published: Jun 2, 2018

There are no references for this article.

You’re reading a free preview. Subscribe to read the entire article.


DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Search

Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly

Organize

Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.

Access

Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

DeepDyve

Freelancer

DeepDyve

Pro

Price

FREE

$49/month
$360/year

Save searches from
Google Scholar,
PubMed

Create lists to
organize your research

Export lists, citations

Read DeepDyve articles

Abstract access only

Unlimited access to over
18 million full-text articles

Print

20 pages / month

PDF Discount

20% off